Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1953 1
1955 2
1977 1
1978 2
1979 5
1980 6
1981 8
1982 7
1983 12
1984 11
1985 2
1986 11
1987 16
1988 13
1989 9
1990 11
1991 11
1992 14
1993 27
1994 25
1995 20
1996 23
1997 30
1998 24
1999 20
2000 20
2001 29
2002 27
2003 25
2004 32
2005 44
2006 37
2007 36
2008 57
2009 52
2010 52
2011 46
2012 52
2013 58
2014 57
2015 67
2016 67
2017 73
2018 67
2019 57
2020 63
2021 59
2022 43
2023 25
2024 33
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,372 results

Results by year

Filters applied: . Clear all
Page 1
Current Challenges in Cancer Treatment.
Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Zugazagoitia J, et al. Among authors: ferrer i. Clin Ther. 2016 Jul;38(7):1551-66. doi: 10.1016/j.clinthera.2016.03.026. Epub 2016 May 2. Clin Ther. 2016. PMID: 27158009 Review.
Tau Aggregation.
Hernández F, Ferrer I, Pérez M, Zabala JC, Del Rio JA, Avila J. Hernández F, et al. Among authors: ferrer i. Neuroscience. 2023 May 10;518:64-69. doi: 10.1016/j.neuroscience.2022.04.024. Epub 2022 May 4. Neuroscience. 2023. PMID: 35525497 Free article. Review.
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions.
Lam I, Ndayisaba A, Lewis AJ, Fu Y, Sagredo GT, Kuzkina A, Zaccagnini L, Celikag M, Sandoe J, Sanz RL, Vahdatshoar A, Martin TD, Morshed N, Ichihashi T, Tripathi A, Ramalingam N, Oettgen-Suazo C, Bartels T, Boussouf M, Schäbinger M, Hallacli E, Jiang X, Verma A, Tea C, Wang Z, Hakozaki H, Yu X, Hyles K, Park C, Wang X, Theunissen TW, Wang H, Jaenisch R, Lindquist S, Stevens B, Stefanova N, Wenning G, van de Berg WDJ, Luk KC, Sanchez-Pernaute R, Gómez-Esteban JC, Felsky D, Kiyota Y, Sahni N, Yi SS, Chung CY, Stahlberg H, Ferrer I, Schöneberg J, Elledge SJ, Dettmer U, Halliday GM, Bartels T, Khurana V. Lam I, et al. Among authors: ferrer i. Neuron. 2024 Sep 4;112(17):2886-2909.e16. doi: 10.1016/j.neuron.2024.06.002. Epub 2024 Jul 29. Neuron. 2024. PMID: 39079530 Free PMC article.
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.
Figarol S, Delahaye C, Gence R, Doussine A, Cerapio JP, Brachais M, Tardy C, Béry N, Asslan R, Colinge J, Villemin JP, Maraver A, Ferrer I, Paz-Ares L, Kessler L, Burrows F, Lajoie-Mazenc I, Dongay V, Morin C, Florent A, Pagano S, Taranchon-Clermont E, Casanova A, Pradines A, Mazieres J, Favre G, Calvayrac O. Figarol S, et al. Among authors: ferrer i. Nat Commun. 2024 Jun 27;15(1):5345. doi: 10.1038/s41467-024-49360-4. Nat Commun. 2024. PMID: 38937474 Free PMC article.
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Macaya I, Roman M, Welch C, Entrialgo-Cadierno R, Salmon M, Santos A, Feliu I, Kovalski J, Lopez I, Rodriguez-Remirez M, Palomino-Echeverria S, Lonfgren SM, Ferrero M, Calabuig S, Ludwig IA, Lara-Astiaso D, Jantus-Lewintre E, Guruceaga E, Narayanan S, Ponz-Sarvise M, Pineda-Lucena A, Lecanda F, Ruggero D, Khatri P, Santamaria E, Fernandez-Irigoyen J, Ferrer I, Paz-Ares L, Drosten M, Barbacid M, Gil-Bazo I, Vicent S. Macaya I, et al. Among authors: ferrer i. Nat Commun. 2023 Oct 10;14(1):6332. doi: 10.1038/s41467-023-41828-z. Nat Commun. 2023. PMID: 37816716 Free PMC article.
Efficient enzyme-free isolation of brain-derived extracellular vesicles.
Matamoros-Angles A, Karadjuzovic E, Mohammadi B, Song F, Brenna S, Meister SC, Siebels B, Voß H, Seuring C, Ferrer I, Schlüter H, Kneussel M, Altmeppen HC, Schweizer M, Puig B, Shafiq M, Glatzel M. Matamoros-Angles A, et al. Among authors: ferrer i. J Extracell Vesicles. 2024 Nov;13(11):e70011. doi: 10.1002/jev2.70011. J Extracell Vesicles. 2024. PMID: 39508423 Free PMC article.
YES1 Is a Druggable Oncogenic Target in SCLC.
Redin E, Garrido-Martin EM, Valencia K, Redrado M, Solorzano JL, Carias R, Echepare M, Exposito F, Serrano D, Ferrer I, Nunez-Buiza A, Garmendia I, García-Pedrero JM, Gurpide A, Paz-Ares L, Politi K, Montuenga LM, Calvo A. Redin E, et al. Among authors: ferrer i. J Thorac Oncol. 2022 Dec;17(12):1387-1403. doi: 10.1016/j.jtho.2022.08.002. Epub 2022 Aug 18. J Thorac Oncol. 2022. PMID: 35988891 Free article.
Neuropathology of cerebrovascular diseases.
Ferrer I, Vidal N. Ferrer I, et al. Handb Clin Neurol. 2017;145:79-114. doi: 10.1016/B978-0-12-802395-2.00007-9. Handb Clin Neurol. 2017. PMID: 28987197 Review.
Incidental corticobasal degeneration.
Martínez-Maldonado A, Luna-Muñoz J, Ferrer I. Martínez-Maldonado A, et al. Among authors: ferrer i. Neuropathol Appl Neurobiol. 2016 Dec;42(7):659-663. doi: 10.1111/nan.12339. Neuropathol Appl Neurobiol. 2016. PMID: 27461552 No abstract available.
1,372 results